NCT07564986|Completed
Loading search results
Sponsor study identifier
observational
80
1 country
1
Study Start
April 1, 2025
Actual (reported)Primary Completion
April 27, 2026
Actual (reported)Study Completion
April 27, 2026
Actual (reported)This study aims to investigate whether a specific protein in the blood, called resistin, can help doctors predict how much dangerous internal fat a patient will lose following weight loss surgery. Sleeve gastrectomy is a common and effective procedure that reduces the stomach's size to help patients lose weight and improve their metabolic health. Beyond just losing weight, it is vital to reduce visceral fat-the fat stored around internal organs-which is closely linked to inflammation and conditions like Type 2 Diabetes. Resistin is a marker known to contribute to insulin resistance and is typically higher in individuals with significant abdominal fat. By measuring resistin levels before surgery, we want to determine if this protein can serve as a guide to predict a patient's internal fat loss and overall metabolic recovery. Ultimately, this research could help healthcare providers better understand the hormonal changes that occur during weight loss and identify which patients may experience the most significant health improvements after the procedure.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 27, 2026
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 1, 2025
Actual (reported)April 27, 2026
Actual (reported)April 27, 2026
Actual (reported)April 27, 2026
Actual (reported)May 4, 2026
Actual (reported)Change in body mass index at 8 months
8 months after surgery
Change in visseral fat at 8 months
8 months after surgery
Change in basal metabolic rate at 8 months
8 months after surgery
Patients who meet inclusion criteria for the study undergoing sleeve gastrectomy
Laparoscopic Sleeve Gastrectomy
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patients applying to Başakşehir Çam Sakura City Hospital General Surgery Clinic for bariatric surgery
Basaksehir Cam and Sakura City Hospital
Istanbul, Basaksehir, 34480, Turkey (Türkiye)
Blood will be centrifuged and serum will be stored separately in eppendorf tubes.
80 participants (actual enrollment reported by the registry).
First Submitted
April 27, 2026
First Posted
May 4, 2026
Study Start
April 1, 2025
Actual (reported)Two-Year Weight Loss With GLP-1 Medications Compared With Sleeve Gastrectomy in Adults With Obesity
Contact the study team to confirm eligibility.
Primary Completion
April 27, 2026
Actual (reported)Study Completion
April 27, 2026
Actual (reported)Last Updated
May 4, 2026
Record last verified: 2026-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: